Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors

被引:4
|
作者
Fiondella, Luigi [1 ,2 ,3 ]
Gami-Patel, Priya A. [4 ]
Blok, Christian [5 ]
Rozemuller, Annemieke J. M. [4 ]
Hoozemans, Jeroen J. M. [4 ]
Pijnenburg, Yolande A. L. A. [1 ,2 ]
Scarioni, Marta [1 ,2 ,6 ]
Dijkstra, Anke [1 ,4 ,5 ]
机构
[1] Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Neurol, Amsterdam UMC Locat VUmc, Boelelaan 1118, NL-1081 HZ Amsterdam, Netherlands
[2] Amsterdam Neurosci, Neurodegenerat, Amsterdam, Netherlands
[3] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy
[4] Univ Amsterdam, Dept Pathol, Amsterdam Neurosci, Med Ctr, Amsterdam, Netherlands
[5] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands
[6] Ghent Univ Hosp, Dept Neurol, Ghent, Belgium
关键词
Frontotemporal Dementia; Frontotemporal Lobar Degeneration; TDP-43; Substantia nigra; Movement disorders; Brain donors; PROGRESSIVE SUPRANUCLEAR PALSY; FRONTOTEMPORAL DEMENTIA; BEHAVIORAL VARIANT; LEWY BODY; PARKINSONISM; DIAGNOSIS; PATHOLOGY; CRITERIA; DISEASE;
D O I
10.1186/s40478-023-01560-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Movement disorders (MD) have been linked to degeneration of the substantia nigra (SN) in Parkinson's disease and include bradykinesia, rigidity, and tremor. They are also present in frontotemporal dementia (FTD), where MD have been linked to frontotemporal lobar degeneration with tau pathology (FTLD-tau). Although MD can also occur in FTLD with TDP-43 pathology (FTLD-TDP), the local pathology in the SN of FTLD-TDP patients with MD is currently unexplored. The aims of this study are to characterize the frequency and the nature of MD in a cohort of FTLD-TDP brain donors and to investigate the relationship between the presence of MD, the nigral neuronal loss, and the TDP-43 burden in the SN. From our cohort of FTLD-TDP patients (n = 53), we included 13 donors who presented with MD (FTLD-MD+), and nine age-sex matched donors without MD (FTLD-MD-) for whom the SN was available. In these donors, the TDP-43 burden and the neuronal density in the SN were assessed with ImageJ and Qupath software. The results were compared between the two groups using T-test. We found that the TDP-43 burden in the SN was higher in FTLD-MD+ (mean 3,43%, SD +/- 2,7) compared to FTLD-MD- (mean 1,21%, SD +/- 0,67) (p = 0,04), while no significant difference in nigral neuronal density was found between the groups (p = 0,09). 17% of FTLD-TDP patients developed MD, which present as symmetric akinetic-rigid parkinsonism or CBS. Given the absence of a significant nigral neuronal cell loss, TDP-43 induced neuronal dysfunction could be sufficient to cause MD.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Transthyretin attenuates TDP-43 proteinopathy by autophagy activation via ATF4 in FTLD-TDP
    Chu, Yuan-Ping
    Jin, Lee-Way
    Wang, Liang-Chao
    Ho, Pei-Chuan
    Wei, Wei-Yen
    Tsai, Kuen-Jer
    BRAIN, 2023, 146 (05) : 2089 - 2106
  • [22] Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders
    Tibor Hortobágyi
    Claire Troakes
    Agnes L. Nishimura
    Caroline Vance
    John C. van Swieten
    Harro Seelaar
    Andrew King
    Safa Al-Sarraj
    Boris Rogelj
    Christopher E. Shaw
    Acta Neuropathologica, 2011, 121 : 519 - 527
  • [23] Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders
    Hortobagyi, Tibor
    Troakes, Claire
    Nishimura, Agnes L.
    Vance, Caroline
    van Swieten, John C.
    Seelaar, Harro
    King, Andrew
    Al-Sarraj, Safa
    Rogelj, Boris
    Shaw, Christopher E.
    ACTA NEUROPATHOLOGICA, 2011, 121 (04) : 519 - 527
  • [24] Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy
    Arai, Tetsuaki
    Hasegawa, Masato
    Nonoka, Takashi
    Kametani, Fuyuki
    Yamashita, Makiko
    Hosokawa, Masato
    Niizato, Kazuhiro
    Tsuchiya, Kuniaki
    Kobayashi, Zen
    Ikeda, Kenji
    Yoshida, Mari
    Onaya, Mitsumoto
    Fujishiro, Hiroshige
    Akiyama, Haruhiko
    NEUROPATHOLOGY, 2010, 30 (02) : 170 - 181
  • [25] Amyloid fibrils from frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) are composed of TMEM106B, rather than TDP-43
    Jiang, Yi Xiao
    Cao, Qin
    Sawaya, Michael R.
    Abskharon, Romany
    Ge, Peng
    DeTure, Michael
    Dickson, Dennis W.
    Eisenberg, David S.
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 349A - 349A
  • [26] Mapping Cell Type and Transcriptomic Changes Associated with TDP-43 Pathology in LATE-NC and FTLD-TDP
    Pinarbasi, E.
    Barmada, S.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (06): : 480 - 480
  • [27] ANXA11 is a significant aggregating disease protein in FTLD-TDP Type C and related TDP-43 proteinopathies
    Robinson, J.
    Suh, E.
    Xu, Y.
    Van Deerlin, V.
    Porta, S.
    Lee, E.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (06): : 435 - 435
  • [28] A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP)
    Armstrong, R. A.
    Carter, D.
    Cairns, N. J.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2012, 38 (01) : 25 - 38
  • [29] TDP-43 Vasculopathy in the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis (sALS) and Frontal Cortex in sALS/FTLD-TDP
    Ferrer, Isidro
    Andres-Benito, Pol
    Carmona, Margarita
    Assialioui, Abdelilah
    Povedano, Monica
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (03): : 229 - 239
  • [30] Antibody against TDP-43 phosphorylated at serine 369 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes (vol 140, pg 645, 2020)
    Neumann, Manuela
    Frick, Petra
    Paron, Francesca
    Kosten, Jonas
    Buratti, Emanuele
    Mackenzie, Ian R.
    ACTA NEUROPATHOLOGICA, 2021, 141 (01) : 137 - 137